These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 14761355)
1. [Renal dysfunction in workers exposed to arsenic and cadmium]. Hong F; Jin TY; Lu GD; Yin ZY Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec; 21(6):432-6. PubMed ID: 14761355 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers of cadmium and arsenic interactions. Nordberg GF; Jin T; Hong F; Zhang A; Buchet JP; Bernard A Toxicol Appl Pharmacol; 2005 Aug; 206(2):191-7. PubMed ID: 15967208 [TBL] [Abstract][Full Text] [Related]
3. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method]. Hong F; Jin TY; Zhang AH Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers]. Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085 [TBL] [Abstract][Full Text] [Related]
5. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China. Chen L; Jin T; Huang B; Nordberg G; Nordberg M Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161 [TBL] [Abstract][Full Text] [Related]
6. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters. Lei LJ; Chen L; Jin TY; Nordberg M; Chang XL Toxicol Sci; 2007 May; 97(1):189-95. PubMed ID: 17303580 [TBL] [Abstract][Full Text] [Related]
7. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Chen L; Jin T; Huang B; Chang X; Lei L; Nordberg GF; Nordberg M Toxicol Sci; 2006 May; 91(1):104-12. PubMed ID: 16322080 [TBL] [Abstract][Full Text] [Related]
8. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Hong F; Jin T; Zhang A Biometals; 2004 Oct; 17(5):573-80. PubMed ID: 15688868 [TBL] [Abstract][Full Text] [Related]
9. [Application of Benchmark dose (BMD) in estimating biological exposure limit (BEL)]. Shao B; Jin TY; Qian HL; Wu XW; Kong QH; Ye TT Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):20-2. PubMed ID: 16600088 [TBL] [Abstract][Full Text] [Related]
10. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure. Chang X; Jin T; Chen L; Nordberg M; Lei L Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654 [TBL] [Abstract][Full Text] [Related]
11. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead]. Milnerowicz H; BizoĆ A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537 [TBL] [Abstract][Full Text] [Related]
12. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead. Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606 [TBL] [Abstract][Full Text] [Related]
13. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan. Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China. Nordberg GF Toxicol Lett; 2010 Jan; 192(1):45-9. PubMed ID: 19540908 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors. Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860 [TBL] [Abstract][Full Text] [Related]
16. Association between renal effects and cadmium exposure in cadmium-nonpolluted area in Japan. Yamanaka O; Kobayashi E; Nogawa K; Suwazono Y; Sakurada I; Kido T Environ Res; 1998 Apr; 77(1):1-8. PubMed ID: 9593622 [TBL] [Abstract][Full Text] [Related]
17. Risk assessment of low-level cadmium and arsenic on the kidney. Huang M; Choi SJ; Kim DW; Kim NY; Park CH; Yu SD; Kim DS; Park KS; Song JS; Kim H; Choi BS; Yu IJ; Park JD J Toxicol Environ Health A; 2009; 72(21-22):1493-8. PubMed ID: 20077223 [TBL] [Abstract][Full Text] [Related]
18. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships. Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016 [TBL] [Abstract][Full Text] [Related]
19. The reference dose for subchronic exposure of pigs to cadmium leading to early renal damage by benchmark dose method. Wu X; Wei S; Wei Y; Guo B; Yang M; Zhao D; Liu X; Cai X Toxicol Sci; 2012 Aug; 128(2):524-31. PubMed ID: 22610606 [TBL] [Abstract][Full Text] [Related]